With new offerings from Neutrogena (R) and OGX (R) , consumers gain unique, science-led solutions tailored to diverse hair and scalp needs. Both collections begin rolling out this fall, with ...
New Neutrogena Hair Restore and OGX ProGrowth + Peptide systems address the need for accessible hair growth solutions.
As OGX and Neutrogena gear up to release product ranges feeding into the ‘skinification’ of hair, Cosmetics Business sat down ...
In addition to Tylenol, Kenvue production facilities roll out essential name-brand health products like Neosporin, Motrin and ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...
Kimberly-Clark has demonstrated its ambitions in the consumer healthcare segment after agreeing to buy Neutrogena, Tylenol ...
The global Ceramide Skincare Market is on a steady growth trajectory, projected to rise from USD 448.9 million in 2025 to USD 781.5 million by 2035, registering a CAGR of 5.7% over the forecast period ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...
The news comes as Kenvue maker Tylenol has been embroiled in litigation surrounding the alleged relationship between Tylenol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results